| Target- | 
| Mechanism- | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.Japan | 
| First Approval Date01 Nov 1986 | 
| Target- | 
| Mechanism- | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.Japan | 
| First Approval Date01 Oct 1986 | 
| Target- | 
| Mechanism- | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.Japan | 
| First Approval Date01 Oct 1986 | 
100 Clinical Results associated with Taiko Seido Pharmaceutical Co., Ltd
0  Patents (Medical) associated with Taiko Seido Pharmaceutical Co., Ltd
100 Deals associated with Taiko Seido Pharmaceutical Co., Ltd
100 Translational Medicine associated with Taiko Seido Pharmaceutical Co., Ltd